Anaxis Pharma is an Australian Biotech company developing novel inhibitors / modulators of cell death, specifically necroptosis, an inflammatory form of programmed cell death. This process, involving both kinases and pseudokinases, is central to and dysregulated in chronic inflammatory disease. Targ...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2017 (7 years) |
Funding status Private |
Company type SME |
Lead Biologist
Assay development specialist -Screening Lab
Chief Operating Officer